Detalhe da pesquisa
1.
Provisional standardization of hepcidin assays: creating a traceability chain with a primary reference material, candidate reference method and a commutable secondary reference material.
Clin Chem Lab Med
; 57(6): 864-872, 2019 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30485171
2.
Effect of calcitriol on serum hepcidin in individuals with chronic kidney disease: a randomized controlled trial.
BMC Nephrol
; 19(1): 35, 2018 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29426300
3.
Iron-related markers are associated with infection after liver transplantation.
Liver Transpl
; 23(12): 1541-1552, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28703464
4.
Iron overload results in hepatic oxidative stress, immune cell activation, and hepatocellular ballooning injury, leading to nonalcoholic steatohepatitis in genetically obese mice.
Am J Physiol Gastrointest Liver Physiol
; 310(2): G117-27, 2016 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26564716
5.
Toward Worldwide Hepcidin Assay Harmonization: Identification of a Commutable Secondary Reference Material.
Clin Chem
; 62(7): 993-1001, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27173010
6.
A Novel Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial.
Am J Kidney Dis
; 67(6): 861-71, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26827289
7.
Increased hepcidin in transferrin-treated thalassemic mice correlates with increased liver BMP2 expression and decreased hepatocyte ERK activation.
Haematologica
; 101(3): 297-308, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26635037
8.
Prevalence of anemia and associations between neonatal iron status, hepcidin, and maternal iron status among neonates born to pregnant adolescents.
Pediatr Res
; 79(1-1): 42-8, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26383884
9.
Evidence of relative iron deficiency in platelet- and plasma-pheresis donors correlates with donation frequency.
J Clin Apher
; 31(6): 551-558, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26915437
10.
Normalizing hepcidin predicts TMPRSS6 mutation status in patients with chronic iron deficiency.
Blood
; 132(4): 448-452, 2018 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29895660
11.
A competitive enzyme-linked immunosorbent assay specific for murine hepcidin-1: correlation with hepatic mRNA expression in established and novel models of dysregulated iron homeostasis.
Haematologica
; 100(2): 167-77, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25425686
12.
Altered erythropoiesis and iron metabolism in carriers of thalassemia.
Eur J Haematol
; 94(6): 511-8, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25307880
13.
Combination therapy with a Tmprss6 RNAi-therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of ß-thalassemia intermedia.
Am J Hematol
; 90(4): 310-3, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25557851
14.
Suppression of iron-regulatory hepcidin by vitamin D.
J Am Soc Nephrol
; 25(3): 564-72, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24204002
15.
Combination of biomarkers for diagnosis of acute kidney injury after cardiopulmonary bypass.
Ren Fail
; 37(3): 408-16, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25585949
16.
Placental heme receptor LRP1 correlates with the heme exporter FLVCR1 and neonatal iron status.
Reproduction
; 148(3): 295-302, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24947444
17.
Maternal inflammation at delivery affects assessment of maternal iron status.
J Nutr
; 144(10): 1524-32, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25080540
18.
Erythropoiesis-driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15.
Am J Hematol
; 89(4): 385-90, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24860871
19.
Bone marrow stromal cell-derived hepcidin has antimicrobial and immunomodulatory activities.
Sci Rep
; 14(1): 3986, 2024 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38368463
20.
Effects of subcutaneous and intravenous golimumab on inflammatory biomarkers in patients with rheumatoid arthritis: results of a phase 1, randomized, open-label trial.
Rheumatology (Oxford)
; 52(7): 1214-9, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23418046